Mobilized and apheresis‐collected endothelial progenitor cells with plerixafor
Journal of Clinical Apheresis2022Vol. 37(3), pp. 245–252
Citations Over Time
Susana Perdomo, Andreína Brugnini, Natalia Trías, Alba Menyou, Gonzalo Silveira, Sabrina Ranero, Daniela Lens, Lilián Díaz, Sofía Grille
Abstract
We have shown that plerixafor in combination with G-CSF allows the mobilization and collection of large amounts of EPCs along with CD34+ cells in lymphoid neoplasm patients. The possibility to collect and to store these cells could represent a promising therapeutic tool for the treatment of ischemic complications without the need of in vitro expansion.
Related Papers
- → A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure(2012)33 cited
- → Risks of leukapheresis and how to manage them—A non-systematic review(2018)22 cited
- → Successful Mobilization of Autologous Hematopoietic Peripheral Blood Stem Cells after Salvage Chemotherapy in Patients with Low CD34 Blood Cell Counts(2022)6 cited
- → Circulating CD34+ cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing Tumor patients(1997)13 cited
- → Apheresis: An Overview of Procedures and Need for Vascular Access Devices(2004)2 cited